Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASPOFUNGIN vs CEFDINIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASPOFUNGIN vs CEFDINIR: Safety Overview

Metric CASPOFUNGIN CEFDINIR
Total FAERS Reports 3,814 1,627
Deaths Reported 1,419 35
Death Rate 37.2% 2.2%
Hospitalizations 1,638 262
Average Patient Age 47.5 yrs 37.8 yrs
% Female Patients 42.8% 65.6%
FDA Approval Date Dec 30, 2016 Apr 6, 2007
Manufacturer Sandoz Inc Sandoz Inc
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued